CALCIUM FOLINATE

CALCIUM FOLINATE was reported 4736 times

CALCIUM FOLINATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FLUID BALANCE POSITIVE 3 0.2000
1 VENOUS PRESSURE JUGULAR DECREASED 3 0.0789
2 HUMAN BOCAVIRUS INFECTION 14 0.0741
3 CHEMOTHERAPY TOXICITY ATTENUATION 2 0.0714
4 VISCERAL VENOUS THROMBOSIS 4 0.0667
5 ASTRINGENT THERAPY 2 0.0645
6 CONGENITAL TOXOPLASMOSIS 3 0.0556
7 CHEMOTHERAPEUTIC DRUG LEVEL ABOVE THERAPEUTIC 3 0.0484
8 MYCOBACTERIUM CHELONAE INFECTION 31 0.0419
9 KOEBNER PHENOMENON 4 0.0417
10 ABSCESS BACTERIAL 15 0.0413
11 LEUKOERYTHROBLASTOSIS 4 0.0400
12 PROSTATIC CALCIFICATION 5 0.0391
13 TRACHEAL INFLAMMATION 4 0.0367
14 NICOTINIC ACID DEFICIENCY 4 0.0360
15 ENCAPSULATING PERITONEAL SCLEROSIS 6 0.0337
16 APPENDICITIS NONINFECTIVE 2 0.0333
17 SECONDARY IMMUNODEFICIENCY 39 0.0321
18 ACINETOBACTER SEPSIS 2 0.0312
19 OVERGROWTH FUNGAL 3 0.0291
20 K-RAS GENE MUTATION 3 0.0283
21 CORONA VIRUS INFECTION 12 0.0279
22 COMA ACIDOTIC 2 0.0238
23 TERATOGENICITY 7 0.0232
24 NEUTROPENIA NEONATAL 5 0.0223
25 ACCESSORY SPLEEN 2 0.0222
26 PELVIC PROLAPSE 4 0.0222
27 PSEUDOMONAL SEPSIS 38 0.0217
28 NOROVIRUS TEST POSITIVE 7 0.0215
29 OCULAR PROCEDURAL COMPLICATION 4 0.0206
30 HIV VIRAEMIA 4 0.0190
31 GASTROENTERITIS RADIATION 6 0.0183
32 ANAEMIA OF MALIGNANT DISEASE 5 0.0179
33 COLORECTAL ADENOCARCINOMA 4 0.0179
34 CYSTITIS BACTERIAL 6 0.0178
35 THYMUS HYPOPLASIA 3 0.0172
36 NASAL SEPTUM PERFORATION 11 0.0170
37 ANAL PROLAPSE 2 0.0169
38 CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME 2 0.0161
39 GLOMERULONEPHRITIS CHRONIC 3 0.0160
40 CHOLINERGIC SYNDROME 10 0.0157
41 CATHETER SITE THROMBOSIS 4 0.0146
42 DIFFUSE ALVEOLAR DAMAGE 16 0.0139
43 CANDIDURIA 2 0.0135
44 ECG SIGNS OF MYOCARDIAL ISCHAEMIA 3 0.0132
45 PARAINFLUENZAE VIRUS INFECTION 20 0.0131
46 FOETAL DISORDER 10 0.0120
47 CRANIAL NERVE DISORDER 8 0.0114
48 OESOPHAGEAL ATRESIA 7 0.0112
49 PORTAL VENOUS GAS 4 0.0110
50 BONE MARROW TOXICITY 13 0.0110
51 ENTEROBACTER INFECTION 18 0.0107
52 PNEUMOTHORAX SPONTANEOUS 7 0.0103
53 CYTOMEGALOVIRUS CHORIORETINITIS 20 0.0102
54 TISSUE INFILTRATION 3 0.0102
55 PELVIC FLUID COLLECTION 7 0.0099
56 BONE FORMATION INCREASED 2 0.0099
57 BONE MARROW FAILURE 195 0.0096
58 RETROPERITONEAL ABSCESS 3 0.0095
59 PERINEAL ABSCESS 4 0.0089
60 ANASTOMOTIC COMPLICATION 3 0.0087
61 RHINOCEREBRAL MUCORMYCOSIS 3 0.0086
62 ADENOCARCINOMA OF COLON 16 0.0085
63 ECZEMA ASTEATOTIC 4 0.0085
64 HUMAN HERPESVIRUS 6 INFECTION 16 0.0085
65 PROTEUS INFECTION 6 0.0084
66 STOMAL HERNIA 3 0.0082
67 NAIL PSORIASIS 5 0.0081
68 PNEUMATOSIS INTESTINALIS 23 0.0081
69 COLORECTAL CANCER METASTATIC 19 0.0080
70 MYELOID LEUKAEMIA 4 0.0080
71 PERIPHERAL SENSORIMOTOR NEUROPATHY 10 0.0080
72 BLOOD ALKALINE PHOSPHATASE ABNORMAL 7 0.0078
73 PROTEIN URINE 7 0.0077
74 ADENOIDAL DISORDER 2 0.0077
75 SKIN CANDIDA 4 0.0077
76 GASTROENTERITIS NOROVIRUS 10 0.0075
77 CHOLANGITIS INFECTIVE 2 0.0075
78 RECTAL PERFORATION 4 0.0074
79 SPLENIC ABSCESS 3 0.0074
80 COLON CANCER RECURRENT 2 0.0072
81 MOTOR DEVELOPMENTAL DELAY 4 0.0069
82 ABDOMINAL SEPSIS 6 0.0068
83 STOMA SITE PAIN 10 0.0068
84 SUBILEUS 14 0.0067
85 SKIN TOXICITY 38 0.0067
86 VENA CAVA THROMBOSIS 11 0.0066
87 ENTEROVESICAL FISTULA 5 0.0066
88 ENTERITIS 42 0.0066
89 EXTRAOCULAR MUSCLE PARESIS 3 0.0065
90 AIR EMBOLISM 3 0.0064
91 ANAL INFLAMMATION 4 0.0063
92 DERMATITIS ACNEIFORM 38 0.0062
93 EXOSTOSIS OF JAW 3 0.0060
94 PERITONSILLAR ABSCESS 5 0.0060
95 VIRAEMIA 8 0.0058
96 ANASTOMOTIC LEAK 4 0.0058
97 GRANULOMATOUS LIVER DISEASE 4 0.0057
98 NEUROTOXICITY 99 0.0056
99 OESOPHAGEAL CANDIDIASIS 22 0.0055
100 PORTAL HYPERTENSION 17 0.0055
101 DISORGANISED SPEECH 10 0.0054
102 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 3 0.0054
103 CEREBRAL TOXOPLASMOSIS 5 0.0054
104 PROTHROMBIN LEVEL DECREASED 5 0.0053
105 BACTERIURIA 3 0.0053
106 SENSE OF OPPRESSION 6 0.0051
107 VENOUS THROMBOSIS 20 0.0051
108 THYROID HORMONES DECREASED 4 0.0050
109 HAPTOGLOBIN DECREASED 4 0.0050
110 RECTAL ADENOCARCINOMA 3 0.0050
111 BRONCHOPULMONARY ASPERGILLOSIS 38 0.0049
112 CHANGE OF BOWEL HABIT 10 0.0049
113 TUMOUR NECROSIS 5 0.0047
114 FEBRILE BONE MARROW APLASIA 20 0.0047
115 MUCOSAL INFLAMMATION 123 0.0047
116 PERITONEAL DISORDER 3 0.0046
117 DRUG CLEARANCE DECREASED 6 0.0046
118 HYPERSENSITIVITY VASCULITIS 12 0.0046
119 VASCULAR DEMENTIA 4 0.0046
120 GENE MUTATION 9 0.0045
121 SUBCLAVIAN VEIN THROMBOSIS 5 0.0044
122 THROMBOCYTOPENIC PURPURA 6 0.0044
123 PLEURAL THICKENING 3 0.0044
124 GASTROINTESTINAL TOXICITY 21 0.0044
125 BILIARY SEPSIS 2 0.0043
126 PARONYCHIA 19 0.0043
127 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 100 0.0043
128 EMBOLISM VENOUS 13 0.0043
129 CYTOMEGALOVIRUS VIRAEMIA 19 0.0043
130 ANAPHYLACTOID SHOCK 2 0.0043
131 KLEBSIELLA BACTERAEMIA 4 0.0042
132 NEUTROPENIC INFECTION 4 0.0042
133 NEOPLASM RECURRENCE 14 0.0041
134 RECTAL TENESMUS 5 0.0040
135 ADENOCARCINOMA 9 0.0040
136 JUGULAR VEIN THROMBOSIS 7 0.0039
137 IMMUNE THROMBOCYTOPENIC PURPURA 11 0.0039
138 RHINOVIRUS INFECTION 15 0.0039
139 ESCHERICHIA BACTERAEMIA 9 0.0038
140 CARBOHYDRATE ANTIGEN 19-9 INCREASED 2 0.0038
141 NEUTROPENIC SEPSIS 27 0.0038
142 GRANULOCYTE COUNT DECREASED 7 0.0038
143 LEUKOENCEPHALOPATHY 14 0.0038
144 LARYNGOSPASM 10 0.0037
145 TOXOPLASMOSIS 4 0.0037
146 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 3 0.0037
147 LEUKOCYTURIA 3 0.0036
148 GASTROINTESTINAL PERFORATION 15 0.0036
149 PERIPHERAL SENSORY NEUROPATHY 21 0.0036
150 PARESIS 8 0.0036
151 RECTAL ABSCESS 6 0.0036
152 APLASIA 7 0.0036
153 KLEBSIELLA SEPSIS 4 0.0035
154 HEPATIC CANCER METASTATIC 3 0.0035
155 TUMOUR HAEMORRHAGE 10 0.0035
156 WOUND COMPLICATION 12 0.0035
157 PELVIC ABSCESS 4 0.0035
158 MACROCYTOSIS 4 0.0034
159 RADIATION SKIN INJURY 4 0.0034
160 ACUTE ABDOMEN 5 0.0034
161 FEBRILE INFECTION 4 0.0034
162 CLOSTRIDIUM DIFFICILE COLITIS 36 0.0034
163 HAEMATOTOXICITY 32 0.0034
164 GASTROINTESTINAL WALL THICKENING 5 0.0033
165 DYSPLASIA 4 0.0033
166 MOUTH INJURY 5 0.0033
167 VASOSPASM 3 0.0033
168 ADENOCARCINOMA GASTRIC 3 0.0032
169 BLOOD ALKALINE PHOSPHATASE DECREASED 3 0.0032
170 BACTERIAL INFECTION 59 0.0032
171 RED CELL DISTRIBUTION WIDTH INCREASED 13 0.0031
172 ADENOCARCINOMA PANCREAS 4 0.0031
173 CHORIORETINITIS 2 0.0031
174 PROTEINURIA 59 0.0031
175 COLON CANCER METASTATIC 5 0.0031
176 POLYNEUROPATHY 37 0.0031
177 DUODENAL PERFORATION 3 0.0031
178 DEVICE RELATED THROMBOSIS 3 0.0030
179 MUCOSAL DISORDER 3 0.0030
180 SECOND PRIMARY MALIGNANCY 25 0.0030
181 FEBRILE NEUTROPENIA 196 0.0030
182 EYE COLOUR CHANGE 3 0.0029
183 ENTERITIS INFECTIOUS 5 0.0029
184 HYPERAMMONAEMIC ENCEPHALOPATHY 5 0.0029
185 METASTASES TO PLEURA 3 0.0029
186 PRERENAL FAILURE 4 0.0028
187 INDURATION 5 0.0028
188 LIVER ABSCESS 9 0.0028
189 CHOLANGITIS 17 0.0027
190 ARTERIOSPASM CORONARY 11 0.0027
191 NEOPLASM PROGRESSION 95 0.0027
192 OCULAR TOXICITY 3 0.0027
193 PNEUMOPERITONEUM 5 0.0027
194 COMA HEPATIC 2 0.0027
195 NEUTROPENIA 364 0.0027
196 INTESTINAL PERFORATION 30 0.0027
197 LIP ULCERATION 3 0.0026
198 BILE DUCT STENOSIS 3 0.0025
199 RASH PUSTULAR 18 0.0025
200 PANCREATIC CARCINOMA METASTATIC 7 0.0025
201 ASPERGILLUS INFECTION 16 0.0024
202 QUADRIPLEGIA 5 0.0024
203 ILEUS 30 0.0024
204 NECROTISING COLITIS 3 0.0024
205 NEUROPATHY PERIPHERAL 224 0.0024
206 ENDOCARDITIS 12 0.0023
207 SLOW RESPONSE TO STIMULI 3 0.0023
208 OBLITERATIVE BRONCHIOLITIS 3 0.0023
209 THROMBOPHLEBITIS 8 0.0023
210 INTRACARDIAC THROMBUS 7 0.0023
211 TUMOUR PAIN 3 0.0023
212 NECROTISING FASCIITIS 8 0.0023
213 OESOPHAGEAL HAEMORRHAGE 3 0.0023
214 JAUNDICE CHOLESTATIC 8 0.0023
215 LARGE INTESTINAL OBSTRUCTION 5 0.0022
216 CANDIDA SEPSIS 2 0.0022
217 METASTASES TO LYMPH NODES 15 0.0022
218 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 21 0.0022
219 APHTHOUS STOMATITIS 5 0.0022
220 NEUTROPHIL COUNT DECREASED 87 0.0021
221 RESPIRATORY SYMPTOM 6 0.0021
222 LYMPHADENOPATHY MEDIASTINAL 4 0.0021
223 CLOSTRIDIAL INFECTION 7 0.0021
224 CARCINOEMBRYONIC ANTIGEN INCREASED 4 0.0021
225 GASTROINTESTINAL NECROSIS 6 0.0021
226 HYPOALBUMINAEMIA 16 0.0021
227 PANCREATIC ENZYMES INCREASED 3 0.0020
228 BILIARY DILATATION 3 0.0020
229 BICYTOPENIA 4 0.0020
230 CARDIOTOXICITY 18 0.0020
231 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
232 KLEBSIELLA INFECTION 10 0.0020
233 RECTAL CANCER 6 0.0020
234 HEPATOSPLENOMEGALY 5 0.0019
235 VENOUS THROMBOSIS LIMB 4 0.0019
236 TUMOUR LYSIS SYNDROME 17 0.0019
237 THROMBOCYTOPENIA 216 0.0019
238 LIVEDO RETICULARIS 4 0.0019
239 HEPATITIS E 3 0.0019
240 LEUKOPENIA 93 0.0019
241 PORTAL VEIN THROMBOSIS 6 0.0019
242 METASTASES TO LIVER 32 0.0018
243 ILLUSION 3 0.0018
244 MEAN CELL HAEMOGLOBIN INCREASED 3 0.0018
245 BLOOD CALCIUM ABNORMAL 3 0.0018
246 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
247 HYPOMAGNESAEMIA 25 0.0018
248 FEMALE GENITAL TRACT FISTULA 3 0.0018
249 GRANULOCYTOPENIA 10 0.0018
250 CACHEXIA 9 0.0017
251 CENTRAL NERVOUS SYSTEM INFECTION 2 0.0017
252 CARBON DIOXIDE DECREASED 2 0.0017
253 BLOOD CHLORIDE INCREASED 3 0.0017
254 NEUROLOGICAL DECOMPENSATION 4 0.0017
255 VASCULAR PSEUDOANEURYSM 3 0.0017
256 MYELOSUPPRESSION 62 0.0017
257 BLOOD LACTIC ACID INCREASED 9 0.0017
258 ANAL FISTULA 9 0.0017
259 URINARY TRACT OBSTRUCTION 4 0.0017
260 EMBOLISM 14 0.0017
261 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
262 LYMPHADENITIS 4 0.0017
263 FACIAL PARALYSIS 14 0.0016
264 MEAN CELL HAEMOGLOBIN DECREASED 3 0.0016
265 INTESTINAL OBSTRUCTION 61 0.0016
266 MOUTH ULCERATION 34 0.0016
267 PERSECUTORY DELUSION 4 0.0016
268 HYPERAMMONAEMIA 8 0.0016
269 BLOOD CREATININE DECREASED 5 0.0016
270 ENCEPHALITIS 11 0.0016
271 ENCEPHALOPATHY 39 0.0016
272 LARGE INTESTINE PERFORATION 11 0.0016
273 HYPOPROTEINAEMIA 3 0.0016
274 NON-CARDIAC CHEST PAIN 5 0.0016
275 TONGUE OEDEMA 6 0.0016
276 OSTEOPOROTIC FRACTURE 3 0.0016
277 DEVICE RELATED INFECTION 24 0.0016
278 METASTASES TO LUNG 18 0.0016
279 PULMONARY TOXICITY 11 0.0016
280 STRESS CARDIOMYOPATHY 9 0.0015
281 BILIARY OBSTRUCTION 2 0.0015
282 MUCORMYCOSIS 4 0.0015
283 HERPES SIMPLEX 10 0.0015
284 PSYCHIATRIC DECOMPENSATION 3 0.0015
285 ASCITES 45 0.0015
286 ACQUIRED GENE MUTATION 2 0.0015
287 HYPERAEMIA 3 0.0015
288 LOW BIRTH WEIGHT BABY 12 0.0015
289 STOMATITIS 91 0.0015
290 LEFT VENTRICULAR DYSFUNCTION 10 0.0015
291 HYPERLACTACIDAEMIA 4 0.0015
292 CEREBRAL HAEMATOMA 5 0.0015
293 PANCYTOPENIA 83 0.0015
294 ANAL ABSCESS 8 0.0015
295 WOUND DEHISCENCE 5 0.0015
296 HEPATIC CYST 5 0.0015
297 PURPURA 13 0.0015
298 PIGMENTATION DISORDER 9 0.0015
299 CENTRAL NERVOUS SYSTEM LYMPHOMA 2 0.0015
300 BRONCHIAL OBSTRUCTION 2 0.0014
301 ALVEOLITIS 2 0.0014
302 AGRANULOCYTOSIS 26 0.0014
303 ESCHERICHIA SEPSIS 4 0.0014
304 ADENOVIRUS INFECTION 4 0.0014
305 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 3 0.0014
306 THROMBOCYTOSIS 5 0.0014
307 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
308 APRAXIA 2 0.0013
309 SKIN NECROSIS 7 0.0013
310 HISTIOCYTOSIS HAEMATOPHAGIC 4 0.0013
311 JAUNDICE 36 0.0013
312 HYDRONEPHROSIS 10 0.0013
313 METABOLIC ENCEPHALOPATHY 4 0.0013
314 ACUTE CORONARY SYNDROME 11 0.0013
315 METASTASES TO MENINGES 3 0.0013
316 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
317 CYTOPENIA 16 0.0013
318 INTERSTITIAL LUNG DISEASE 63 0.0013
319 PNEUMOCYSTIS JIROVECII PNEUMONIA 13 0.0013
320 HAEMOLYTIC URAEMIC SYNDROME 3 0.0013
321 VIRAL INFECTION 43 0.0013
322 MULTIPLE-DRUG RESISTANCE 4 0.0013
323 HEPATIC ENCEPHALOPATHY 12 0.0013
324 PERFORMANCE STATUS DECREASED 6 0.0013
325 VITILIGO 3 0.0013
326 INTESTINAL ISCHAEMIA 7 0.0013
327 LIVER INJURY 31 0.0013
328 GINGIVAL PAIN 10 0.0013
329 LACUNAR INFARCTION 3 0.0013
330 DISEASE PROGRESSION 146 0.0012
331 LYMPHOCYTE COUNT INCREASED 4 0.0012
332 DEVICE INFUSION ISSUE 3 0.0012
333 DISSEMINATED INTRAVASCULAR COAGULATION 17 0.0012
334 SKIN REACTION 17 0.0012
335 CYTOLYTIC HEPATITIS 4 0.0012
336 PROTEIN URINE PRESENT 6 0.0012
337 SPLENOMEGALY 14 0.0012
338 METASTASES TO PERITONEUM 3 0.0012
339 HEPATIC FUNCTION ABNORMAL 44 0.0012
340 HYPERTHERMIA 9 0.0012
341 ABDOMINAL INFECTION 3 0.0012
342 MEAN CELL VOLUME INCREASED 3 0.0012
343 NEPHROTIC SYNDROME 8 0.0012
344 AORTIC ARTERIOSCLEROSIS 3 0.0012
345 BLOOD CHLORIDE DECREASED 3 0.0012
346 HEPATITIS B 7 0.0012
347 HEPATIC LESION 5 0.0012
348 ACUTE MYELOID LEUKAEMIA 18 0.0012
349 STATUS EPILEPTICUS 13 0.0011
350 HYPOKALAEMIA 53 0.0011
351 RENAL CYST 9 0.0011
352 CYTOMEGALOVIRUS INFECTION REACTIVATION 5 0.0011
353 ABDOMINAL ABSCESS 5 0.0011
354 SEPTIC SHOCK 49 0.0011
355 AREFLEXIA 3 0.0011
356 WHITE BLOOD CELL DISORDER 3 0.0011
357 POST PROCEDURAL INFECTION 9 0.0011
358 MYELODYSPLASTIC SYNDROME 16 0.0011
359 MONOCYTE COUNT INCREASED 4 0.0011
360 TOXIC SKIN ERUPTION 11 0.0011
361 PULMONARY EMBOLISM 102 0.0011
362 PROCTITIS 3 0.0011
363 DRUG TOLERANCE DECREASED 3 0.0011
364 RENAL TUBULAR DISORDER 3 0.0011
365 CHRONIC SINUSITIS 4 0.0011
366 ACUTE LYMPHOCYTIC LEUKAEMIA 3 0.0011
367 HEPATOCELLULAR INJURY 15 0.0011
368 SMALL INTESTINAL OBSTRUCTION 13 0.0011
369 PETECHIAE 11 0.0011
370 SARCOIDOSIS 5 0.0011
371 PRE-ECLAMPSIA 5 0.0011
372 VIRAL UPPER RESPIRATORY TRACT INFECTION 5 0.0011
373 SEPSIS 117 0.0010
374 GASTRIC INFECTION 4 0.0010
375 CHOLESTASIS 20 0.0010
376 GASTROINTESTINAL DISORDER 93 0.0010
377 VENOOCCLUSIVE LIVER DISEASE 5 0.0010
378 BACTERAEMIA 12 0.0010
379 ORGANISING PNEUMONIA 5 0.0010
380 BLOOD CULTURE POSITIVE 3 0.0010
381 RIGHT VENTRICULAR FAILURE 7 0.0010
382 GAMMA-GLUTAMYLTRANSFERASE INCREASED 22 0.0010
383 DUODENAL ULCER 7 0.0010
384 LYMPHOPENIA 14 0.0010
385 DYSCHEZIA 3 0.0010
386 PETIT MAL EPILEPSY 5 0.0010
387 BLOOD CALCIUM DECREASED 11 0.0010
388 DEMYELINATION 4 0.0010
389 UROSEPSIS 9 0.0010
390 ESCHERICHIA INFECTION 8 0.0010
391 OLIGURIA 6 0.0010
392 BLOOD ALKALINE PHOSPHATASE INCREASED 24 0.0010
393 FAILURE TO THRIVE 5 0.0010
394 HEPATIC FAILURE 29 0.0010
395 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
396 PNEUMONITIS 26 0.0010
397 ABDOMINAL ADHESIONS 3 0.0009
398 HYPERPYREXIA 4 0.0009
399 BUNDLE BRANCH BLOCK LEFT 4 0.0009
400 BLOOD TEST ABNORMAL 13 0.0009
401 BODY TEMPERATURE DECREASED 9 0.0009
402 CEREBELLAR SYNDROME 2 0.0009
403 HAEMATOCRIT DECREASED 18 0.0009
404 WHITE BLOOD CELL COUNT DECREASED 98 0.0009
405 HYPOTONIA 9 0.0009
406 VENTRICULAR FIBRILLATION 10 0.0009
407 SKIN MASS 6 0.0009
408 INTRACRANIAL PRESSURE INCREASED 5 0.0009
409 HAEMOLYTIC ANAEMIA 8 0.0009
410 METASTASES TO SPINE 3 0.0009
411 COLITIS ISCHAEMIC 6 0.0009
412 MALIGNANT NEOPLASM PROGRESSION 91 0.0009
413 NEUTROPHILIA 5 0.0009
414 MYOCARDIAL ISCHAEMIA 10 0.0009
415 ACUTE GRAFT VERSUS HOST DISEASE 4 0.0009
416 GENERAL PHYSICAL HEALTH DETERIORATION 101 0.0009
417 COLON CANCER 13 0.0009
418 CONJUNCTIVITIS 16 0.0009
419 BILIRUBIN CONJUGATED INCREASED 2 0.0009
420 HEPATOTOXICITY 19 0.0009
421 HICCUPS 7 0.0009
422 TYPE I HYPERSENSITIVITY 3 0.0009
423 SUDDEN DEATH 9 0.0008
424 ORAL PAIN 19 0.0008
425 HAEMORRHAGIC DIATHESIS 3 0.0008
426 ANAEMIA 160 0.0008
427 SUBCUTANEOUS ABSCESS 4 0.0008
428 RESPIRATORY DISTRESS 23 0.0008
429 CANDIDA INFECTION 14 0.0008
430 LEUKOCYTOSIS 15 0.0008
431 NEURALGIA 20 0.0008
432 BLOOD PHOSPHORUS DECREASED 3 0.0008
433 VENTRICULAR ARRHYTHMIA 3 0.0008
434 PNEUMOTHORAX 13 0.0008
435 ORAL HERPES 16 0.0008
436 BRONCHITIS CHRONIC 2 0.0008
437 ANURIA 7 0.0008
438 AMYLASE INCREASED 3 0.0008
439 CARDIOMYOPATHY 12 0.0008
440 ABDOMINAL TENDERNESS 4 0.0008
441 MALNUTRITION 9 0.0008
442 FISTULA 9 0.0008
443 CATHETER SITE HAEMORRHAGE 2 0.0008
444 TOXIC ENCEPHALOPATHY 4 0.0008
445 TROPONIN INCREASED 6 0.0008
446 DRUG LEVEL INCREASED 13 0.0008
447 MYOCARDITIS 9 0.0008
448 PHLEBITIS 4 0.0008
449 THERAPEUTIC PRODUCT INEFFECTIVE 3 0.0008
450 VARICOSE VEIN 4 0.0008
451 CATHETER SITE PAIN 2 0.0008
452 EPIGASTRIC DISCOMFORT 3 0.0008
453 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
454 PREMATURE BABY 23 0.0008
455 CORONAVIRUS INFECTION 5 0.0008
456 CYSTITIS 24 0.0008
457 NYSTAGMUS 4 0.0008
458 HYPERTENSION 159 0.0007
459 EPISTAXIS 56 0.0007
460 CHOLECYSTITIS CHRONIC 5 0.0007
461 MUSCLE DISORDER 6 0.0007
462 HYPOCALCAEMIA 14 0.0007
463 COLD SWEAT 13 0.0007
464 BODY TEMPERATURE INCREASED 15 0.0007
465 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
466 EXTRAVASATION 3 0.0007
467 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 6 0.0007
468 SPINAL COMPRESSION FRACTURE 6 0.0007
469 DIARRHOEA 468 0.0007
470 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0007
471 TRANSAMINASES INCREASED 16 0.0007
472 RASH MACULO-PAPULAR 16 0.0007
473 ONYCHOMADESIS 3 0.0007
474 ANAL HAEMORRHAGE 2 0.0007
475 HEMIPARESIS 12 0.0007
476 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
477 PYREXIA 242 0.0007
478 PLATELET COUNT DECREASED 74 0.0007
479 ENTEROCOLITIS 4 0.0007
480 PYELONEPHRITIS 6 0.0007
481 THERAPEUTIC PRODUCT EFFECT DECREASED 31 0.0007
482 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
483 NAIL DISORDER 6 0.0007
484 APATHY 10 0.0007
485 ORAL CANDIDIASIS 9 0.0007
486 HYPERTRIGLYCERIDAEMIA 4 0.0007
487 MELAENA 15 0.0007
488 BLOOD CREATINE INCREASED 3 0.0007
489 HYPOPHOSPHATAEMIA 5 0.0007
490 CHILLS 79 0.0007
491 ILEUS PARALYTIC 3 0.0007
492 COAGULOPATHY 11 0.0007
493 RENAL FAILURE ACUTE 28 0.0007
494 ABDOMINAL PAIN 152 0.0007
495 LOCALISED OEDEMA 3 0.0006
496 BRAIN DEATH 2 0.0006
497 GENERALISED OEDEMA 8 0.0006
498 LUNG INFECTION 10 0.0006
499 BLOOD CREATININE INCREASED 42 0.0006
500 DIARRHOEA HAEMORRHAGIC 6 0.0006
501 OESOPHAGITIS 7 0.0006
502 PNEUMONIA ASPIRATION 16 0.0006
503 PULMONARY HAEMORRHAGE 5 0.0006
504 WOUND INFECTION 7 0.0006
505 CHRONIC LYMPHOCYTIC LEUKAEMIA 3 0.0006
506 LYMPHOCYTE COUNT DECREASED 11 0.0006
507 SENSORY LOSS 5 0.0006
508 ATELECTASIS 6 0.0006
509 DERMATITIS 13 0.0006
510 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
511 HAEMATURIA 21 0.0006
512 HEPARIN-INDUCED THROMBOCYTOPENIA 3 0.0006
513 MUSCLE TWITCHING 14 0.0006
514 DEPRESSED LEVEL OF CONSCIOUSNESS 24 0.0006
515 ELECTROLYTE IMBALANCE 7 0.0006
516 HYPERNATRAEMIA 3 0.0006
517 CARDIAC FAILURE ACUTE 4 0.0006
518 DERMATITIS EXFOLIATIVE 3 0.0006
519 LIVE BIRTH 5 0.0006
520 APHASIA 18 0.0006
521 TOXIC EPIDERMAL NECROLYSIS 9 0.0006
522 PATHOLOGICAL FRACTURE 3 0.0006
523 HEPATIC STEATOSIS 11 0.0006
524 TACHYPNOEA 8 0.0006
525 CIRCULATORY COLLAPSE 10 0.0006
526 VOMITING 275 0.0006
527 ASPARTATE AMINOTRANSFERASE INCREASED 31 0.0006
528 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
529 CEREBRAL ISCHAEMIA 3 0.0006
530 RECTAL HAEMORRHAGE 25 0.0006
531 SKIN HYPERPIGMENTATION 5 0.0006
532 APLASIA PURE RED CELL 2 0.0006
533 ORTHOSTATIC HYPOTENSION 10 0.0006
534 CYANOSIS 9 0.0006
535 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
536 COMA 27 0.0006
537 BONE EROSION 2 0.0006
538 METASTASIS 4 0.0006
539 DYSARTHRIA 21 0.0006
540 BLOOD BILIRUBIN INCREASED 15 0.0006
541 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
542 HAEMATEMESIS 14 0.0006
543 OPTIC NEURITIS 5 0.0005
544 ACUTE KIDNEY INJURY 84 0.0005
545 ANAPHYLACTIC SHOCK 14 0.0005
546 DENTAL CARIES 6 0.0005
547 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
548 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
549 NECROSIS 3 0.0005
550 ALANINE AMINOTRANSFERASE INCREASED 33 0.0005
551 CARDIAC DYSFUNCTION 2 0.0005
552 ERYTHEMA MULTIFORME 5 0.0005
553 NEPHROPATHY TOXIC 6 0.0005
554 PANCREATITIS ACUTE 12 0.0005
555 FACE OEDEMA 9 0.0005
556 PERITONITIS 11 0.0005
557 BLOOD SODIUM DECREASED 10 0.0005
558 PULMONARY HYPERTENSION 11 0.0005
559 GENERALISED ERYTHEMA 3 0.0005
560 AFFECT LABILITY 5 0.0005
561 PERICARDIAL EFFUSION 12 0.0005
562 HAEMOLYSIS 4 0.0005
563 HYPERVENTILATION 3 0.0005
564 RALES 3 0.0005
565 THERAPY PARTIAL RESPONDER 8 0.0005
566 HYPOVOLAEMIA 3 0.0005
567 FUNGAL INFECTION 17 0.0005
568 SKIN DISORDER 17 0.0005
569 PLEURAL EFFUSION 31 0.0005
570 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
571 BLOOD ALBUMIN DECREASED 4 0.0005
572 CLOSTRIDIUM DIFFICILE INFECTION 11 0.0005
573 CHOLECYSTITIS 6 0.0005
574 ULCER 8 0.0005
575 COLITIS 19 0.0005
576 RESPIRATORY TRACT INFECTION 13 0.0005
577 OXYGEN SATURATION DECREASED 28 0.0005
578 LACRIMATION INCREASED 15 0.0005
579 EMPHYSEMA 5 0.0005
580 DECREASED APPETITE 115 0.0005
581 DEHYDRATION 66 0.0005
582 C-REACTIVE PROTEIN INCREASED 18 0.0005
583 BRONCHOSPASM 7 0.0005
584 THROAT IRRITATION 22 0.0005
585 RED BLOOD CELL COUNT DECREASED 14 0.0005
586 ANGINA PECTORIS 14 0.0005
587 NEUTROPHIL COUNT INCREASED 5 0.0005
588 ARTHRITIS BACTERIAL 2 0.0005
589 LARYNGEAL OEDEMA 3 0.0005
590 HYPERCALCAEMIA 6 0.0005
591 INFUSION RELATED REACTION 32 0.0005
592 HYPOXIA 17 0.0005
593 HYPERBILIRUBINAEMIA 5 0.0005
594 RENAL FAILURE 64 0.0005
595 CYTOMEGALOVIRUS INFECTION 8 0.0005
596 NERVOUS SYSTEM DISORDER 15 0.0005
597 CONGESTIVE CARDIOMYOPATHY 2 0.0005
598 TENDERNESS 5 0.0005
599 SCRATCH 5 0.0005
600 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
601 PULMONARY MASS 7 0.0005
602 ABSCESS LIMB 2 0.0005
603 NAUSEA 370 0.0005
604 INFLAMMATION 24 0.0005
605 BLOOD MAGNESIUM DECREASED 4 0.0005
606 EAR PAIN 9 0.0005
607 MULTI-ORGAN FAILURE 8 0.0005
608 HAEMOGLOBIN DECREASED 47 0.0005
609 CELLULITIS 23 0.0005
610 SPINAL OSTEOARTHRITIS 4 0.0005
611 LUNG INFILTRATION 4 0.0005
612 RESPIRATORY FAILURE 33 0.0005
613 LIMB DISCOMFORT 14 0.0005
614 HYPERTENSIVE CRISIS 5 0.0004
615 DEEP VEIN THROMBOSIS 29 0.0004
616 OROPHARYNGEAL DISCOMFORT 4 0.0004
617 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
618 GASTROINTESTINAL CARCINOMA 4 0.0004
619 RENAL IMPAIRMENT 37 0.0004
620 TACHYCARDIA 39 0.0004
621 METABOLIC ACIDOSIS 14 0.0004
622 ECCHYMOSIS 3 0.0004
623 CHRONIC MYELOID LEUKAEMIA 2 0.0004
624 RHINORRHOEA 28 0.0004
625 MUSCULAR WEAKNESS 49 0.0004
626 PRODUCT USE IN UNAPPROVED INDICATION 106 0.0004
627 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
628 PAPULE 3 0.0004
629 ARTERIOSCLEROSIS 4 0.0004
630 GASTROINTESTINAL HAEMORRHAGE 35 0.0004
631 BLOOD UREA INCREASED 7 0.0004
632 WHITE BLOOD CELL COUNT INCREASED 16 0.0004
633 ACUTE RESPIRATORY FAILURE 8 0.0004
634 ERYTHEMA 85 0.0004
635 HYPERGLYCAEMIA 15 0.0004
636 UTERINE LEIOMYOMA 3 0.0004
637 ORAL DISORDER 3 0.0004
638 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
639 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
640 INJECTION SITE EXTRAVASATION 5 0.0004
641 HYPERSENSITIVITY 75 0.0004
642 DRUG INTERACTION 64 0.0004
643 LYMPHADENOPATHY 14 0.0004
644 ABDOMINAL PAIN LOWER 10 0.0004
645 VAGINAL DISCHARGE 4 0.0004
646 PARAESTHESIA 62 0.0004
647 ACIDOSIS 3 0.0004
648 AMMONIA INCREASED 2 0.0004
649 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
650 PAIN IN JAW 11 0.0004
651 ANOREXIA 5 0.0004
652 METASTASES TO CENTRAL NERVOUS SYSTEM 5 0.0004
653 HAEMORRHAGIC STROKE 3 0.0004
654 LIVER DISORDER 17 0.0004
655 ASTHENIA 144 0.0004
656 APLASTIC ANAEMIA 2 0.0004
657 DRUG-INDUCED LIVER INJURY 12 0.0004
658 LETHARGY 22 0.0004
659 FOLLICULITIS 4 0.0004
660 BLOOD PRESSURE FLUCTUATION 9 0.0004
661 BLOOD DISORDER 3 0.0004
662 COMPRESSION FRACTURE 2 0.0004
663 JOINT RANGE OF MOTION DECREASED 5 0.0004
664 DYSPNOEA EXERTIONAL 14 0.0004
665 SHOCK HAEMORRHAGIC 3 0.0004
666 GASTRIC ULCER 7 0.0004
667 SKIN LACERATION 4 0.0004
668 INFECTION 53 0.0004
669 BLOOD POTASSIUM DECREASED 11 0.0004
670 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
671 EPILEPSY 11 0.0004
672 STEVENS-JOHNSON SYNDROME 8 0.0004
673 ANGIOPATHY 2 0.0004
674 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
675 ACUTE PULMONARY OEDEMA 2 0.0004
676 CHOLECYSTITIS ACUTE 2 0.0004
677 SINUS TACHYCARDIA 5 0.0004
678 DRUG INTOLERANCE 34 0.0004
679 PSEUDOMONAS INFECTION 3 0.0003
680 THROMBOSIS 28 0.0003
681 SHOCK 8 0.0003
682 PARAESTHESIA ORAL 5 0.0003
683 TASTE DISORDER 7 0.0003
684 HYPERKALAEMIA 12 0.0003
685 IMMUNOSUPPRESSION 3 0.0003
686 TOXICITY TO VARIOUS AGENTS 57 0.0003
687 ATAXIA 4 0.0003
688 HYPERLIPIDAEMIA 4 0.0003
689 THROAT TIGHTNESS 9 0.0003
690 LIP DRY 3 0.0003
691 OEDEMA PERIPHERAL 40 0.0003
692 DISORIENTATION 13 0.0003
693 DYSURIA 12 0.0003
694 EMOTIONAL DISORDER 10 0.0003
695 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
696 HYPOTENSION 65 0.0003
697 ALOPECIA 63 0.0003
698 HYPONATRAEMIA 18 0.0003
699 FATIGUE 248 0.0003
700 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
701 BLEPHAROSPASM 2 0.0003
702 ARRHYTHMIA 15 0.0003
703 CARDIAC ARREST 26 0.0003
704 TOOTH DISORDER 7 0.0003
705 OEDEMA 17 0.0003
706 HERPES ZOSTER 18 0.0003
707 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
708 THROMBOTIC MICROANGIOPATHY 3 0.0003
709 HAEMORRHOIDS 6 0.0003
710 FOETAL EXPOSURE DURING PREGNANCY 25 0.0003
711 SKIN FISSURES 6 0.0003
712 ABDOMINAL DISTENSION 32 0.0003
713 HEPATOMEGALY 3 0.0003
714 IMPAIRED HEALING 10 0.0003
715 STAPHYLOCOCCAL INFECTION 10 0.0003
716 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
717 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
718 PERITONITIS BACTERIAL 3 0.0003
719 HYPOTHERMIA 3 0.0003
720 ILL-DEFINED DISORDER 18 0.0003
721 HYPERHIDROSIS 38 0.0003
722 TOOTH ABSCESS 3 0.0003
723 SUBARACHNOID HAEMORRHAGE 3 0.0003
724 PALLOR 8 0.0003
725 GINGIVAL BLEEDING 4 0.0003
726 TEMPERATURE INTOLERANCE 3 0.0003
727 POOR VENOUS ACCESS 3 0.0003
728 CONSTIPATION 63 0.0003
729 EYE DISCHARGE 3 0.0003
730 HYPOAESTHESIA 43 0.0003
731 HAEMORRHAGE 30 0.0003
732 CEREBRAL INFARCTION 7 0.0003
733 DEVICE OCCLUSION 4 0.0003
734 URINARY TRACT INFECTION 48 0.0003
735 PNEUMONIA 91 0.0003
736 PARALYSIS 4 0.0003
737 CARDIOGENIC SHOCK 4 0.0003
738 ACCIDENTAL OVERDOSE 10 0.0003
739 DRUG RESISTANCE 7 0.0003
740 COLORECTAL CANCER 13 0.0003
741 CONFUSIONAL STATE 44 0.0003
742 BLINDNESS TRANSIENT 2 0.0003
743 FOOT DEFORMITY 3 0.0003
744 URINARY INCONTINENCE 8 0.0003
745 URINARY RETENTION 9 0.0003
746 SPEECH DISORDER 14 0.0003
747 PHOTOPHOBIA 5 0.0003
748 LUNG DISORDER 13 0.0003
749 BRADYCARDIA 14 0.0003
750 INTERNAL HAEMORRHAGE 3 0.0003
751 PULMONARY FIBROSIS 5 0.0003
752 GLAUCOMA 5 0.0003
753 ATRIOVENTRICULAR BLOCK 2 0.0003
754 FEMUR FRACTURE 8 0.0003
755 APHTHOUS ULCER 2 0.0003
756 ATRIAL FIBRILLATION 25 0.0003
757 DYSPHONIA 15 0.0003
758 HEART RATE DECREASED 9 0.0003
759 RHEUMATOID ARTHRITIS 29 0.0003
760 AFFECTIVE DISORDER 2 0.0003
761 HAEMOPTYSIS 7 0.0003
762 MUSCLE RIGIDITY 3 0.0003
763 ATRIAL FLUTTER 2 0.0003
764 SENSORY DISTURBANCE 4 0.0002
765 FULL BLOOD COUNT DECREASED 5 0.0002
766 CHOLELITHIASIS 8 0.0002
767 OSTEOPOROSIS 10 0.0002
768 OSTEONECROSIS OF JAW 6 0.0002
769 VENTRICULAR TACHYCARDIA 4 0.0002
770 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
771 DEATH 208 0.0002
772 RASH 105 0.0002
773 MUSCULOSKELETAL STIFFNESS 21 0.0002
774 CARDIO-RESPIRATORY ARREST 10 0.0002
775 BRAIN OEDEMA 3 0.0002
776 CARDIAC FAILURE 19 0.0002
777 HYPOPHAGIA 6 0.0002
778 HEPATITIS 6 0.0002
779 ARTHROPATHY 13 0.0002
780 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
781 IMMUNE SYSTEM DISORDER 3 0.0002
782 ISCHAEMIC STROKE 4 0.0002
783 SYNOVITIS 4 0.0002
784 PELVIC PAIN 4 0.0002
785 SYNCOPE 22 0.0002
786 MENTAL STATUS CHANGES 6 0.0002
787 HUNGER 3 0.0002
788 APPENDICITIS 2 0.0002
789 HEPATIC CIRRHOSIS 4 0.0002
790 FEELING HOT 13 0.0002
791 BLOOD PRESSURE DECREASED 14 0.0002
792 RASH ERYTHEMATOUS 10 0.0002
793 IMPAIRED QUALITY OF LIFE 3 0.0002
794 POST PROCEDURAL COMPLICATION 4 0.0002
795 ERUCTATION 4 0.0002
796 DYSTONIA 4 0.0002
797 GASTROENTERITIS 3 0.0002
798 ABDOMINAL PAIN UPPER 42 0.0002
799 OFF LABEL USE 178 0.0002
800 BLOOD PRESSURE INCREASED 31 0.0002
801 DELIRIUM 7 0.0002
802 CYTOKINE RELEASE SYNDROME 4 0.0002
803 HAEMATOCHEZIA 11 0.0002
804 THERAPEUTIC RESPONSE DECREASED 12 0.0002
805 FEEDING DISORDER 4 0.0002
806 FLUSHING 20 0.0002
807 COUGH 55 0.0002
808 TINNITUS 9 0.0002
809 DRUG EFFECT INCOMPLETE 7 0.0002
810 DYSPHAGIA 18 0.0002
811 DISEASE RECURRENCE 9 0.0002
812 PANCREATITIS 10 0.0002
813 CHEST PAIN 35 0.0002
814 DYSGEUSIA 14 0.0002
815 MALAISE 81 0.0002
816 DYSPNOEA 104 0.0002
817 METASTASES TO BONE 3 0.0002
818 PHOTOSENSITIVITY REACTION 3 0.0002
819 DIVERTICULITIS 5 0.0002
820 PULMONARY OEDEMA 8 0.0002
821 RASH PAPULAR 4 0.0002
822 SNEEZING 4 0.0002
823 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
824 GAIT DISTURBANCE 33 0.0002
825 WEIGHT DECREASED 48 0.0002
826 CAESAREAN SECTION 2 0.0002
827 ACUTE MYOCARDIAL INFARCTION 5 0.0002
828 DRUG ERUPTION 3 0.0002
829 CEREBRAL HAEMORRHAGE 6 0.0002
830 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
831 MYOCARDIAL INFARCTION 29 0.0002
832 GASTROENTERITIS VIRAL 3 0.0002
833 CHEST DISCOMFORT 17 0.0002
834 LOCALISED INFECTION 4 0.0002
835 BURSITIS 2 0.0002
836 NEOPLASM MALIGNANT 11 0.0002
837 ADRENAL INSUFFICIENCY 2 0.0002
838 PRESYNCOPE 4 0.0002
839 CONDITION AGGRAVATED 50 0.0002
840 RESTLESSNESS 6 0.0002
841 BACK PAIN 38 0.0002
842 CARDIOMEGALY 2 0.0002
843 FLATULENCE 9 0.0002
844 TREMOR 26 0.0002
845 UNRESPONSIVE TO STIMULI 4 0.0002
846 RASH GENERALISED 4 0.0002
847 LACTIC ACIDOSIS 5 0.0002
848 DIPLOPIA 4 0.0002
849 DEAFNESS 4 0.0002
850 GASTRITIS 4 0.0002
851 UPPER LIMB FRACTURE 3 0.0002
852 PAIN OF SKIN 4 0.0001
853 PRODUCT ADMINISTRATION ERROR 3 0.0001
854 LOSS OF CONSCIOUSNESS 19 0.0001
855 PAIN 91 0.0001
856 VERTIGO 9 0.0001
857 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
858 HOT FLUSH 11 0.0001
859 RIB FRACTURE 3 0.0001
860 SKIN LESION 4 0.0001
861 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
862 RESPIRATORY ARREST 4 0.0001
863 ANAPHYLACTIC REACTION 8 0.0001
864 HYPOGLYCAEMIA 7 0.0001
865 WOUND 4 0.0001
866 NASOPHARYNGITIS 26 0.0001
867 CONVULSION 8 0.0001
868 PANCREATIC CARCINOMA 4 0.0001
869 DRY MOUTH 11 0.0001
870 DRY SKIN 18 0.0001
871 CHROMATURIA 3 0.0001
872 HEPATIC ENZYME INCREASED 9 0.0001
873 NEPHROLITHIASIS 6 0.0001
874 SEIZURE 15 0.0001
875 BASAL CELL CARCINOMA 2 0.0001
876 SWOLLEN TONGUE 4 0.0001
877 PRODUCTIVE COUGH 6 0.0001
878 PAIN IN EXTREMITY 37 0.0001
879 ABSCESS 2 0.0001
880 PRURITUS 48 0.0001
881 INTENTIONAL OVERDOSE 8 0.0001
882 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
883 BLOOD POTASSIUM INCREASED 2 0.0001
884 BLINDNESS 5 0.0001
885 DYSPEPSIA 12 0.0001
886 OSTEONECROSIS 4 0.0001
887 EYE DISORDER 4 0.0001
888 DRUG ABUSE 10 0.0001
889 MUSCLE SPASMS 22 0.0001
890 AGGRESSION 6 0.0001
891 URTICARIA 20 0.0001
892 SKIN EXFOLIATION 10 0.0001
893 CARDIOVASCULAR DISORDER 3 0.0001
894 OSTEOARTHRITIS 5 0.0001
895 ARTHRALGIA 49 0.0001
896 NERVOUSNESS 6 0.0001
897 ECZEMA 6 0.0001
898 MUSCULOSKELETAL PAIN 6 0.0001
899 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
900 HEADACHE 71 0.0001
901 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
902 FREQUENT BOWEL MOVEMENTS 3 0.0001
903 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
904 FEELING COLD 3 0.0001
905 DEMENTIA 3 0.0001
906 SINUSITIS 11 0.0001
907 EYE PAIN 6 0.0001
908 SOMNOLENCE 21 0.0001
909 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
910 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
911 CHOKING 2 0.0001
912 PSYCHOTIC DISORDER 3 0.0001
913 RENAL INJURY 3 0.0001
914 BURNING SENSATION 7 0.0001
915 JOINT SWELLING 12 0.0001
916 DISCOMFORT 6 0.0001
917 INJECTION SITE RASH 3 0.0001
918 DRUG ADMINISTRATION ERROR 3 0.0001
919 MOBILITY DECREASED 7 0.0001
920 OROPHARYNGEAL PAIN 9 0.0001
921 INFLUENZA LIKE ILLNESS 8 0.0001
922 POLLAKIURIA 4 0.0001
923 PRODUCT USE ISSUE 18 0.0001
924 VISION BLURRED 13 0.0001
925 MOOD SWINGS 3 0.0001
926 HIP FRACTURE 3 0.0001
927 DISTURBANCE IN ATTENTION 5 0.0001
928 RASH PRURITIC 5 0.0001
929 AMNESIA 6 0.0001
930 COLITIS ULCERATIVE 4 0.0001
931 VISUAL IMPAIRMENT 11 0.0001
932 CEREBROVASCULAR ACCIDENT 15 0.0001
933 OVERDOSE 19 0.0001
934 PALPITATIONS 10 0.0001
935 BONE PAIN 5 0.0001
936 NASAL CONGESTION 5 0.0001
937 BRONCHITIS 6 0.0001
938 EYE SWELLING 3 0.0001
939 EXPOSURE DURING PREGNANCY 5 0.0001
940 DRY EYE 4 0.0001
941 DIABETES MELLITUS 6 0.0001
942 DIZZINESS 39 0.0001
943 SWELLING FACE 5 0.0001
944 PRODUCT DOSE OMISSION 5 0.0001
945 FALL 25 0.0001
946 DYSKINESIA 3 0.0001
947 TREATMENT FAILURE 6 0.0001
948 NECK PAIN 4 0.0001
949 ABDOMINAL DISCOMFORT 12 0.0001
950 FEELING ABNORMAL 17 0.0001
951 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
952 EYE IRRITATION 4 0.0001
953 DEVICE DISLOCATION 3 0.0001
954 DRUG INEFFECTIVE 90 0.0001
955 ANGIOEDEMA 3 0.0001
956 CATARACT 4 0.0001
957 WEIGHT INCREASED 15 0.0001
958 THERAPY NON-RESPONDER 3 0.0001
959 HALLUCINATION 5 0.0001
960 CARDIAC DISORDER 6 0.0001
961 INSOMNIA 17 0.0001
962 ARTHRITIS 5 0.0001
963 CARDIAC FAILURE CONGESTIVE 5 0.0001
964 PROSTATE CANCER 5 0.0001
965 HEART RATE INCREASED 6 0.0001
966 COMPLETED SUICIDE 5 0.0001
967 BALANCE DISORDER 5 0.0001
968 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
969 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
970 ANXIETY 16 0.0001
971 AGITATION 4 0.0001
972 MEDICATION ERROR 3 0.0001
973 WHEEZING 3 0.0001
974 PERIPHERAL SWELLING 7 0.0000
975 INJECTION SITE REACTION 3 0.0000
976 ADVERSE EVENT 4 0.0000
977 COGNITIVE DISORDER 2 0.0000
978 SWELLING 4 0.0000
979 INJURY 3 0.0000
980 SLEEP DISORDER 3 0.0000
981 MYALGIA 7 0.0000
982 INJECTION SITE ERYTHEMA 5 0.0000
983 UNEVALUABLE EVENT 3 0.0000
984 ACNE 3 0.0000
985 DEPRESSION 9 0.0000
986 INFLUENZA 4 0.0000
987 INCORRECT DOSE ADMINISTERED 8 0.0000
988 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
989 BLOOD GLUCOSE INCREASED 6 0.0000
990 CONTUSION 3 0.0000
991 ASTHMA 3 0.0000
992 COVID-19 4 0.0000
993 NO ADVERSE EVENT 4 0.0000
994 PRODUCT DOSE OMISSION ISSUE 5 0.0000
995 INJECTION SITE PAIN 5 0.0000